astragali
radix
ar
also
wellknown
huangqi
china
one
popular
herbal
medicin
wide
appli
year
chines
clinic
deriv
root
astragalu
membranaceu
fisch
bge
membranaceu
fisch
bge
var
mongholicu
bge
hsiao
highli
potent
herb
wide
use
treat
variou
diseas
ar
play
indispens
role
healthcar
throughout
chines
histori
tradit
ar
use
treatment
anemia
weak
fever
wound
chronic
fatigu
multipl
allergi
loss
appetit
uterin
bleed
uterin
prolaps
reason
ar
use
essenti
ingredi
includ
chines
herb
formula
furthermor
ar
popularli
consum
health
food
addit
food
reinforc
vital
energi
bodi
immun
modern
pharmacolog
studi
clinic
practic
indic
ar
possess
variou
biolog
function
immunomodul
antioxid
antiinflamm
antitumor
activ
ar
typic
prepar
water
extract
either
alon
togeth
drug
treat
cardiovascular
diseas
diabet
mellitu
cancer
respiratori
diseas
nervou
system
diseas
forth
ar
shown
contain
isoflavonoid
triterpen
saponin
polysaccharid
trace
element
date
compound
includ
isoflavonoid
saponin
polysaccharid
amino
acid
isol
identifi
ar
variou
biolog
activ
compound
report
among
isoflavonoid
saponin
polysaccharid
three
main
type
benefici
compound
respons
pharmacolog
activ
therapeut
efficaci
ar
major
isoflavonoid
ar
formononetin
ononin
calycosin
glycosid
strengthen
immun
system
boost
energi
promot
health
activ
astragalosid
iv
asiv
vital
saponin
compound
ar
possess
effect
pharmacolog
activ
use
marker
compound
qualiti
assess
ar
addit
kind
astragalu
polysaccharid
ap
identifi
amino
acid
vitamin
trace
element
also
isol
identifi
ar
extens
use
ar
clinic
practic
effect
pharmacolog
function
larg
number
studi
pharmacokinet
characterist
ar
bioactiv
compound
perform
studi
clearli
provid
insight
pharmacokinet
process
bioactiv
compound
ar
vivo
may
help
provid
benefici
inform
safe
effect
applic
ar
studi
wellrecogn
metabol
biotransform
bioactiv
compound
extens
vivo
isoflavonoid
saponin
metabolit
major
type
constitu
absorb
plasma
bioavail
barrier
bb
bodi
mainli
consist
drugmetabol
enzym
dme
efflux
transport
et
expect
signific
impact
pharmacokinet
characterist
ar
paper
give
overview
critic
assess
publish
data
concern
phytochemistri
pharmacolog
pharmacokinet
studi
ar
final
use
ar
person
medicin
base
bb
also
discuss
ar
abound
saponin
content
astragalu
total
triterpen
saponin
ar
rang
mgg
mgg
develop
separ
extract
structur
identif
technolog
approxim
kind
triterpenoid
saponin
far
isol
ar
earli
astrasieversianin
ii
astragalosid
two
cycloartan
triterpen
glycosid
first
isol
identifi
ar
spectroscop
analysi
chemic
degrad
nuclear
magnet
reson
analysi
eight
saponin
ar
isol
base
spectral
data
chemic
structur
establish
astrasieversianin
ii
x
astragalosid
ii
iv
vi
cyclocanthosid
e
g
subsequ
three
new
cycloartanetyp
triterpen
saponin
brachyosid
b
c
one
new
glycosid
cyclocephalosid
ii
isol
togeth
five
known
saponin
includ
astragalosid
ii
iv
cyclocanthosid
e
cycloastragenol
advanc
technolog
import
attach
ar
astragalu
saponin
isol
identifi
four
new
saponin
isol
two
shown
stimul
prolifer
mous
splenocyt
without
signific
cytotox
four
cycloartan
hareftosid
oleananetyp
triterpenoid
hareftosid
e
first
identifi
isol
ar
extens
use
experi
along
esim
hrm
analys
among
variou
astragalu
triterpen
saponin
astragalosid
acetyl
astragalosid
isoastragalosid
soyasaponin
major
four
type
account
saponin
studi
astragalosid
iv
asiv
increasingli
popular
simpl
fast
quantif
method
asiv
establish
ultraperform
liquid
chromatographi
uplcqda
addit
confirm
asiv
main
bioactiv
constitu
among
astragalu
saponin
report
exert
extens
pharmacolog
action
variou
diseas
modern
pharmacolog
experi
indic
asiv
possess
cardiomyocyt
protect
antiag
neuroprotect
antioxid
properti
importantli
asiv
use
one
vital
marker
qualiti
control
ar
chines
pharmacopoeia
well
known
flavonoid
also
one
main
type
benefici
compound
respons
biolog
activ
ar
determin
content
astragalu
flavonoid
ar
rang
mgg
mgg
far
kind
flavonoid
compound
isol
mainli
includ
flavonoid
isoflavon
isoflavan
rosetan
flavonol
isoflavonol
dihydroisoflavon
uplcelectrospray
ioniz
mass
spectrometri
appli
analyz
flavonoid
ar
eight
flavonoid
identifi
cg
ononin
calycosin
formononetin
among
cg
prove
exhibit
sever
pharmacolog
activ
antiinflammatori
antioxid
neuroprotect
activ
importantli
cg
use
anoth
chemic
indic
qualiti
control
ar
chines
pharmacopoeia
addit
formononetin
calycosin
anoth
two
import
isoflavonoid
compon
present
ar
also
extens
studi
effect
variou
pharmacolog
function
three
special
astragalu
flavonoid
includ
pendulon
isoliquiritigenin
sulfuretin
also
isol
ar
rel
difficult
isol
character
individu
ap
macromolecul
complic
chemic
structur
date
ap
isol
mainli
classifi
dextran
heteropolysaccharid
studi
ap
extract
ar
method
water
extractionalcohol
precipit
molecular
weight
extract
determin
gel
filtrat
method
sugar
composit
analysi
tlc
ga
chromatographi
show
consist
rha
xyl
glc
gal
man
fru
molar
ratio
rha
xyl
glc
gal
man
fru
anoth
studi
alcoholsolubl
polysaccharid
asp
also
extract
ar
preliminari
structur
characterist
investig
content
total
sugar
protein
uron
acid
asp
respect
analysi
indic
asp
da
neutral
polysaccharid
compos
arabinos
galactos
glucos
mannos
molar
ratio
pyranos
ring
glycosid
linkag
recent
new
coldwatersolubl
polysaccharid
extract
ar
name
averag
molecular
weight
approxim
da
determin
highperform
gelperm
chromatographi
hpgpc
analysi
consist
rhamnos
arabinos
xylos
mannos
galactos
molar
ratio
chromatographi
gc
analysi
experi
indic
potenti
applic
cancer
treatment
author
investig
effect
differ
temperatur
structur
character
polysaccharid
ar
specif
rotat
scan
electron
microscop
sem
analysi
addit
novel
polysaccharid
name
aerp
extract
industri
arextract
wast
residu
compos
two
compon
code
moreov
structur
two
compon
determin
hplcsecrid
ftir
nmr
analysi
acid
compon
molecular
weight
da
glucan
da
addit
isoflavonoid
saponin
polysaccharid
ar
also
contain
kind
trace
element
rubidium
manganes
copper
chromium
cobalt
scandium
selenium
cesium
iron
molybdenum
zinc
addit
ar
also
contain
type
amino
acid
includ
canavanin
arginin
aspart
acid
asparagin
prolin
alanin
compound
ferul
acid
palmit
acid
coumarin
folic
acid
bitter
element
cholin
linolen
acid
vanil
acid
isoferul
acid
hydroxi
phenyl
acryl
acid
caffeic
acid
daucosterol
lupeol
betain
linol
acid
green
acid
palm
acid
also
identifi
ar
increas
number
experi
confirm
ar
effect
inhibit
cardiovascular
diseas
myocardi
ischemiareperfus
injuri
myocardi
hypertrophi
vascular
endotheli
dysfunct
coronari
heart
diseas
atherosclerosi
cardiac
fibrosi
viral
myocard
main
mechan
treatment
cardiovascular
diseas
ar
main
compon
summar
figur
myocardi
hypertrophi
usual
consid
compensatori
respons
patholog
condit
longterm
hypertrophi
lead
myocardi
inflamm
myocardi
metabol
disord
abnorm
energi
product
myocardi
cell
myocardi
ischemia
hypoxia
heart
failur
sudden
death
well
known
nuclear
factor
famili
transcript
factor
effect
regul
inflammatori
respons
grow
evid
suggest
activ
tolllik
receptor
receptor
activ
downstream
signal
pathway
therebi
promot
product
inflammatori
factor
damag
myocardium
cell
report
asiv
could
attenu
inflammatori
cytokin
inhibit
signal
pathway
isoproterenolinduc
myocardi
hypertrophi
rat
figur
hand
dysfunct
cardiac
energi
biosynthesi
contribut
hypertrophi
proliferatoractiv
coactiv
signal
get
involv
dysfunct
result
anoth
studi
show
asiv
could
protect
isoproterenolinduc
cardiac
hypertrophi
regul
signal
mediat
energi
biosynthesi
figur
moreov
known
calcium
homeostasi
play
import
role
progress
myocardi
hypertrophi
cardiac
hypertrophi
occur
overload
calcium
activ
downstream
calcineurin
promot
nuclear
factor
activ
cell
cytoplasm
transcript
factor
nucleu
activ
calmodulin
ii
kinas
camkii
promot
express
cardiac
hypertrophi
indic
found
ap
could
allevi
augment
intracellular
free
calcium
cardiac
hypertrophi
induc
isoproterenol
upregul
express
calcineurin
transloc
nuclear
factor
activ
cell
nucleu
activ
camkii
reflect
pcamkii
suppress
applic
ap
result
reveal
ap
exert
antihypertroph
action
via
inhibit
camkii
signal
cascad
isoproterenolinduc
cardiac
hypertrophi
rat
figur
sarcoplasm
reticulum
sr
play
import
role
regul
intracellular
calcium
sarcoplasm
reticulum
sr
respons
reuptak
sarcoplasm
calcium
numer
studi
shown
express
markedli
decreas
injur
myocardium
report
ar
promot
express
promot
reuptak
calcium
sr
inhibit
overload
calcium
therebi
inhibit
oxid
stressinduc
cell
apoptosi
cytoskeleton
damag
adriamycininjur
rat
heart
figur
anoth
studi
effect
asiv
heart
failur
author
found
asiv
activ
peroxisom
proliferatoractiv
receptor
alpha
stimul
fatti
acid
increas
cardiac
energi
product
improv
mitochondri
function
effici
serca
heart
failur
pressur
overloadinduc
hf
mice
isol
hypertroph
myocardi
cell
figur
cardiac
fibroblast
repres
total
cell
heart
patholog
characterist
cardiac
fibrosi
infinit
prolifer
fibroblast
excess
deposit
extracellular
matrix
ecm
protein
myocardium
studi
inhibit
hypoxiainduc
myocardi
fibrosi
asiv
observ
asiv
could
inhibit
transient
receptor
potenti
cation
channel
subfamili
member
decreas
intracellular
calcium
decreas
muscl
actin
marker
fibroblast
differenti
inhibit
fibroblast
differenti
fibroblast
inhibit
express
ecm
collagen
marker
cardiac
fibroblast
vivo
vitro
figur
oxid
stress
well
recogn
common
featur
cardiac
fibrosi
damag
myocardium
excess
reactiv
oxygen
speci
ro
activ
mitogenactiv
protein
kinas
mapk
signal
pathway
promot
phosphoryl
three
profibrot
mapk
name
extracellular
signalregul
kinas
erk
cjun
ntermin
kinas
jnk
activ
mapk
signal
pathway
regul
express
nuclear
transcript
factor
fibroblastpromot
factor
ecm
protein
asiv
demonstr
possess
remark
antifibrot
effect
via
antioxid
activ
report
asiv
may
inhibit
isoproterenolinduc
cardiac
fibrosi
suppress
rosmedi
mapk
activ
moreov
excess
ro
promot
product
significantli
promot
cardiac
fibrosi
asiv
also
abl
effect
inhibit
isoproterenolinduc
cardiac
fibroblast
prolifer
collagen
product
neg
regul
rosmedi
upregul
figur
coronari
heart
diseas
chd
anoth
major
cardiovascular
diseas
remain
seriou
public
health
burden
vasoreact
endothelialdepend
coronari
arteri
key
indic
vascular
function
endotheli
dysfunct
character
decreas
nitric
oxid
bioavail
well
known
mainli
produc
endotheli
synthas
eno
major
endotheliumderiv
mediat
control
vascular
dilat
play
import
role
physiolog
patholog
endotheli
cell
function
report
asiv
exert
vasodil
effect
aortic
ring
increas
content
enhanc
eno
releas
via
protein
kinas
b
akt
eno
signal
pathway
figur
asiv
also
found
activ
nuclear
factorerythroid
factor
signal
pathway
promot
express
antioxid
factor
nadph
therebi
scaveng
ro
level
inhibit
oxid
stress
injuri
lipopolysaccharid
lp
induc
vascular
endotheli
cell
injuri
mice
figur
anoth
studi
effect
ar
extract
main
compound
mitochondri
bioenerget
evalu
result
show
ar
water
extract
inhibit
ro
product
possess
strongest
antioxid
activ
protect
effect
cultur
cardiomyocyt
cell
expos
oxid
stress
protect
propos
mediat
increas
spare
respiratori
capac
mitochondri
atp
product
stress
cell
figur
moreov
metalloproteinas
close
relat
hyperhomocysteinemia
induc
cardiovascular
diseas
observ
total
extract
ar
astragalu
saponin
asp
could
increas
product
abnorm
aorta
increas
activ
superoxid
dismutas
sod
decreas
concentr
metalloproteinas
therebi
improv
vascular
endotheli
dysfunct
hyperhomocysteinemia
induc
cardiovascular
diseas
rat
figur
autoimmun
diseas
character
destruct
insulinproduc
beta
cell
pancrea
absolut
insuffici
insulin
secret
lymphocyt
cell
mediat
immun
respons
play
import
role
pathogenesi
main
function
subgroup
cell
includ
cell
cell
normal
physiolog
condit
cell
cell
maintain
dynam
balanc
keep
normal
immun
respons
bodi
stimul
antigen
cell
differenti
cell
cytokin
secret
cell
includ
mediat
cellular
immun
caus
damag
islet
beta
cell
cytokin
secret
cell
includ
mediat
fluid
immun
protect
islet
beta
cell
cytokin
togeth
play
import
role
immun
regul
clinic
ap
wide
use
immunosuppress
agent
substanti
evid
exist
ap
could
downregul
blood
glucos
level
upregul
serum
insulin
concentr
increas
beta
cell
mass
decreas
apoptot
beta
cell
percentag
result
downregul
cytokin
ratio
upregul
gene
express
spleen
streptozotocininduc
mice
addit
also
demonstr
effect
ap
prevent
correct
imbal
cytokin
nonobes
diabet
nod
mice
figur
furthermor
known
close
relat
cell
activ
apoptosi
found
ap
could
upregul
express
muscl
streptozotocininduc
mice
result
apoptosi
cell
may
import
mechan
ap
protect
cell
pancreat
islet
apoptosi
induc
cell
vivo
figur
substanti
evid
exist
improv
insulin
toler
main
mechan
ar
activ
ingredi
treatment
glucos
transport
respons
sugar
transport
relat
insulin
sensit
differ
tissu
organ
one
hand
express
regul
ampactiv
protein
kinas
ampk
hand
bind
insulin
insulin
receptor
induc
phosphoryl
insulin
receptor
substrat
activ
signal
pathway
final
induc
express
demonstr
ap
could
activ
ampk
signal
pathway
promot
express
glucos
metabol
figur
could
also
activ
insulin
signal
pathway
promot
intracellular
vesicl
cell
membran
therebi
enhanc
insulin
sensit
mous
preadipocyt
figur
similarli
also
observ
ar
water
extract
could
prevent
develop
diabet
improv
renal
function
dbdb
mice
regul
signal
pathway
ar
water
extract
could
significantli
improv
diabet
nephropathi
figur
furthermor
glycogen
synthas
recogn
key
compon
surprisingli
larg
number
cellular
process
diseas
dysregul
link
sever
preval
patholog
condit
diabet
andor
insulin
resist
reveal
activ
signal
pathway
produc
inhibit
activ
evid
link
activ
ap
signal
pathway
led
hypothesi
compound
may
play
key
role
regul
glucos
homeostasi
signal
pathway
figur
evid
also
exist
protein
tyrosin
phosphatas
play
import
role
insulin
resist
inhibit
phosphoryl
insulin
signal
pathway
promot
insulin
resist
report
ap
enabl
insulinsensit
hypoglycem
activ
least
part
decreas
elev
express
activ
skelet
muscl
streptozotocininduc
rat
figur
endoplasm
reticulum
er
organel
respons
regul
synthesi
membran
protein
regul
secretori
organ
patholog
stress
state
disturb
homeostasi
er
lead
unfold
misfold
er
lumen
er
stress
respons
cumul
result
show
er
stress
respons
also
one
main
characterist
transcript
activ
play
import
role
regul
er
stress
respons
conclud
ap
inhibit
er
stress
inhibit
activ
express
streptozotocininduc
rat
figur
cumul
find
show
microrna
also
play
vital
role
regul
express
insulin
secretionrel
protein
microrna
microarray
combin
bioinformat
use
screen
differenti
express
micro
mi
rna
treatment
ap
goto
kakizaki
gk
rat
bioinformat
analysi
author
found
differenti
express
microrna
find
provid
evid
promin
differenti
express
gene
may
function
role
er
stress
signal
liver
gk
rat
addit
ap
attenu
insulin
resist
like
upregul
maintain
express
level
decreas
target
mrna
protein
express
level
regul
protein
express
er
stress
signal
pathway
figur
grow
number
studi
suggest
ar
activ
ingredi
also
possess
effect
cur
effect
diabet
complic
includ
diabet
cardiomyopathi
diabet
nephropathi
diabet
retinopathi
cognit
dysfunct
exampl
diabet
cardiomyopathi
character
imbal
myocyt
death
regener
mediat
progress
loss
cardiac
stem
progenitor
cell
cspc
apoptosi
necrosi
due
activ
oxid
stress
diabet
confirm
ap
could
increas
cspc
abund
inhibit
oxid
stressmedi
apoptosi
diabet
heart
streptozotocin
stz
induc
diabet
mice
substanti
evid
exist
diabetesinduc
cardiomyocyt
apoptosi
mainli
mediat
intrins
mitochondrialmedi
apoptot
signal
pathway
extrins
death
receptormedi
apoptot
signal
chang
mitochondri
extracorpor
membran
permeabl
momp
promot
releas
cytochrom
c
mitochondria
cytoplasm
promot
express
apoptoticrel
protein
caspas
caspas
play
vital
role
activ
intrins
mitochondrialmedi
apoptot
signal
pathway
inflammatori
factor
activ
fa
death
receptor
promot
express
proapoptot
protein
caspas
bid
bax
bak
bim
inhibit
express
antiapoptot
protein
bclxl
extrins
apoptot
signal
pathway
conclud
ap
could
effect
reduc
momp
also
inhibit
express
proapoptot
protein
extrins
intrins
pathway
modul
ratio
bax
mitochondria
final
decreas
high
glucoseinduc
cell
apoptosi
figur
addit
cumul
result
show
pathogenesi
diabet
cardiomyopathi
associ
oxid
stress
apoptosi
prolifer
local
cardiac
cell
therefor
inhibit
oxid
stress
believ
import
strategi
therapi
diabet
cardiomyopathi
addit
previou
studi
reveal
erbb
pathway
impair
diabet
cardiomyopathi
cell
suggest
pathway
may
play
import
role
diabet
cardiomyopathi
moreov
improv
glucos
toler
healthi
diabet
rodent
regul
oxid
capac
myocyt
confirm
ap
could
increas
prolifer
inhibit
apoptosi
improv
antioxid
function
includ
reduc
intracellular
ro
level
elev
activ
gshpx
sod
lower
level
mda
activ
pathway
figur
substanti
report
suggest
diabet
heart
character
reduc
glucos
metabol
enhanc
fatti
acid
util
diabet
heart
elev
rate
fatti
acid
oxid
ectop
fat
deposit
subsequ
lipid
peroxid
regulatori
pathway
lead
lipotox
cardiomyopathi
final
result
ventricular
dysfunct
reduc
cardiac
fatti
acid
util
may
improv
cardiac
perform
data
indic
activ
target
gene
involv
myocardi
fatti
acid
uptak
oxid
dbdb
diabet
heart
myosin
heavi
heart
reciproc
repress
ap
administr
dbdb
diabet
mice
figur
high
glucoseinduc
inflamm
renal
microangiopathi
renal
injuri
fibrosi
main
characterist
diabet
nephropathi
lead
caus
endstag
failur
kidney
activ
transcript
factor
suggest
key
step
pathogenesi
diabet
nephropathi
physiolog
condit
bound
inhibitori
protein
nuclear
form
inact
transcript
factor
cytoplasm
exposur
variou
stimuli
oxid
stress
angiotensin
variou
cytokin
releas
rapidli
activ
gene
express
sever
cytokin
chemotact
matrix
protein
involv
inflamm
immunolog
respons
andor
prolifer
may
contribut
accumul
renal
extracellular
matrix
tubulointerstiti
fibrosi
result
kidney
damag
ap
proven
inhibit
express
inflammatori
factor
allevi
diabet
nephropathi
inhibit
signal
pathway
streptozotocininduc
diabet
nephropathi
rat
figur
addit
evid
exist
epithelialmesenchym
transit
emt
transform
growth
factor
tgf
play
import
role
renal
fibrosi
overexpress
promot
express
downstream
smad
promot
emt
process
therebi
promot
renal
fibrosi
patient
diabet
nephropathi
report
asiv
delay
renal
fibrosi
process
diabet
kkay
mice
influenc
signal
pathway
downregul
inhibit
emt
process
figur
besid
endoplasm
reticulum
er
stress
also
play
import
role
pathogenesi
diabet
nephropathi
data
studi
indic
asiv
reduc
er
stress
decreas
proteinuria
attenu
diabet
streptozotocininduc
diabet
rat
might
import
mechan
renoprotect
function
asiv
pathogenesi
diabet
nephropathi
figur
grow
evid
suggest
pathway
pathway
close
link
process
cell
injuri
overexpress
activ
pathway
pathway
promot
renal
injuri
fibrosi
found
overexpress
activ
pathway
pathway
process
podocyt
dedifferenti
mesangi
cell
activ
could
abolish
asiv
treatment
addit
asiv
could
also
improv
renal
function
fibrosi
diabet
kkay
mice
figur
diabet
complic
includ
diabet
retinopathi
cognit
dysfunct
also
could
effect
allevi
ar
bioactiv
compound
observ
asiv
could
prevent
activ
phosphoryl
reliev
retin
ganglion
cell
dysfunct
dbdb
mice
diabet
retinopathi
provid
basi
investig
clinic
efficaci
asiv
prevent
diabet
retinopathi
addit
known
persist
hyperglycemia
caus
brain
tissu
damag
cognit
impair
diabet
patient
ap
hypoglycem
effect
dbdb
diabet
mice
allevi
hyperglycemia
tissu
impair
inhibit
cognit
impair
ar
main
compon
wide
use
treatment
cancer
rehabilit
oper
patient
characterist
increas
cur
effect
reduc
toxic
chemotherapeut
drug
substanti
experi
shown
ar
main
activ
ingredi
pharmacolog
effect
inhibit
prolifer
differenti
cancer
cell
induc
apoptosi
cancer
cell
inhibit
invas
migrat
cancer
cell
reduc
drug
resist
enhanc
immun
function
grow
evid
suggest
main
bioactiv
compound
respons
anticanc
effect
ar
mainli
includ
formononetin
asiv
ap
sever
mechan
link
ar
main
compon
regul
cancer
summar
figur
antitumor
activ
formononetin
extens
studi
report
formononetin
effect
inhibit
variou
tumor
inhibit
prolifer
migrat
invas
tumor
cell
induct
tumor
cell
apoptosi
genom
studi
reveal
signal
one
frequent
deregul
pathway
sever
human
cancer
pathway
play
crucial
role
cancer
cell
prolifer
surviv
motil
metabol
therefor
could
attract
therapeut
target
found
formononetin
could
significantli
inhibit
signal
pathway
induc
apoptosi
cervic
cancer
hela
cell
suppress
xenograft
tumor
growth
nude
mice
indic
formononetin
may
use
anticanc
drug
cervic
cancer
futur
figur
anoth
studi
report
formononetin
also
prevent
tumor
growth
human
breast
cancer
cell
nude
mous
xenograft
caus
cell
cycl
arrest
phase
inactiv
pathway
indic
use
formononetin
prevent
breast
cancer
carcinogenesi
figur
similar
two
studi
found
formononetin
could
exhibit
inhibitori
activ
human
prostat
cancer
cell
human
nonsmal
cell
lung
cancer
cell
induct
cell
cycl
arrest
apoptosi
cancer
cell
demonstr
formononetin
might
potenti
chemoprevent
drug
therapi
lung
cancer
prostat
cancer
besid
well
known
ro
take
part
varieti
cellular
activ
includ
surviv
prolifer
apoptosi
migrat
low
ro
concentr
promot
cell
surviv
excess
ro
product
easili
caus
dna
damag
induc
cell
apoptosi
recent
one
studi
reveal
formononetin
could
significantli
suppress
tumor
growth
multipl
myeloma
xenograft
mous
model
without
exhibit
signific
advers
effect
exhibit
signific
anticanc
effect
multipl
myeloma
cell
may
primarili
mediat
increas
rosregul
inhibit
janu
kinas
jak
signal
transduc
transcript
activ
stat
signal
cascad
figur
addit
compel
studi
demonstr
put
oncogen
could
promot
tumor
cell
prolifer
migrat
neg
regul
target
phosphatas
tensin
homolog
pten
function
tumor
suppressor
gene
bladder
cancer
observ
bladder
cancer
cell
expos
formononetin
display
obviou
morpholog
chang
apoptosi
lower
invas
express
significantli
decreas
cell
follow
increas
pten
downregul
phosphoryl
homolog
akt
pakt
suggest
formononetin
exert
anticarcinogen
effect
cell
via
regul
ptenakt
pathway
figur
accumul
evid
suggest
chemoresist
major
obstacl
success
chemotherapi
glioma
epithelialmesenchym
transit
emt
induc
epitheli
cell
transform
mesenchym
phenotyp
exert
import
role
regul
chemoresist
properti
glioma
histon
deacetylas
member
class
ii
histon
deacetylas
famili
shown
play
critic
role
cell
prolifer
cell
cycl
progress
apoptosi
could
promot
glioma
cell
prolifer
might
provid
novel
therapeut
target
treatment
glioma
found
formononetin
may
enhanc
therapeut
efficaci
doxorubicin
glioma
cell
prevent
emt
inhibit
figur
compel
studi
demonstr
asiv
also
exhibit
inhibitori
activ
cancer
exampl
asiv
could
inhibit
migrat
prolifer
nonsmal
cell
lung
cancer
nsclc
cell
caus
notic
increas
cell
death
via
inhibit
signal
axi
author
therefor
propos
asiv
repres
promis
novel
agent
treatment
nsclc
figur
protooncogen
identifi
import
molecul
tumorigenesi
tumor
growth
cell
migrat
oncogen
activ
mediat
differ
downstream
pathway
includ
mitogenactiv
protein
kinas
mapk
pathway
studi
support
hypothesi
asiv
inhibit
viabil
invas
potenti
breast
cancer
cell
suppress
mediat
mapk
signal
pathway
downregul
express
matrix
metalloproteas
mmp
figur
similar
asiv
suppress
migrat
invas
abil
glioma
cell
via
block
mapkerk
signal
pathway
vitro
vivo
besid
accumul
evid
demonstr
tumorassoci
macrophag
tam
play
vital
role
cancer
progress
metastasi
make
polar
tam
ever
appeal
target
therapeut
intervent
observ
asiv
could
reduc
growth
invas
migrat
angiogenesi
lung
cancer
block
polar
macrophag
partial
ampk
signal
pathway
figur
addit
emt
known
multistag
reprogram
process
promot
metastasi
initi
execut
emt
could
trigger
growth
factor
transform
growth
factor
evid
exist
asiv
could
inhibit
emt
inhibit
pathway
gastric
cancer
cell
suggest
asiv
might
effect
candid
treatment
gastric
cancer
figur
similar
asiv
could
suppress
level
inflammatori
factor
also
decreas
level
emt
relat
factor
integrin
inhibit
migrat
invas
human
lung
cancer
cell
via
regul
pathway
fasfasl
signal
pathway
key
modul
cancer
cell
apoptosi
reduc
fasfasl
express
conduc
tumor
progress
asiv
also
exert
anticarcinogen
effect
human
osteosarcoma
via
induct
apoptosi
regul
caspasedepend
fasfasl
signal
addit
recent
find
suggest
long
noncod
rna
lncrna
crucial
role
hepatocellular
carcinoma
hcc
initi
progress
among
lncrna
long
noncod
rna
activ
lncrnaatb
first
identifi
hcc
function
lncrnaatb
promot
emt
metastasi
hcc
cell
also
promot
surviv
hcc
cell
via
activ
signal
data
studi
indic
asiv
could
downregul
lncrnaatb
express
repress
emt
migrat
hcc
cell
moreov
downregul
lncrnaatb
asiv
inactiv
signal
induc
hcc
cell
apoptosi
decreas
hcc
cell
viabil
data
provid
novel
molecular
basi
applic
asiv
therapi
hcc
figur
accumul
evid
suggest
ap
also
possess
effect
antitumor
activ
exampl
ap
delay
growth
human
lung
cancer
cell
line
xenograft
balbc
nude
mice
vivo
inhibit
prolifer
human
lung
cancer
cell
line
via
inhibit
activ
transcript
activ
ap
also
observ
apoptosisinduc
effect
human
gastric
carcinoma
cell
via
arrest
cell
cycl
phase
induc
intrins
mitochondri
apoptosi
pathway
besid
notch
protein
notch
transmembran
receptor
involv
transcript
regul
demonstr
regul
cell
prolifer
apoptosi
differenti
lung
carcinoma
downregul
inhibit
cell
growth
induc
apoptosi
ovarian
cancer
cell
demonstr
ap
could
induc
apoptosi
human
hcc
cell
decreas
express
figur
ap
also
prove
repress
prolifer
migrat
invas
induc
apoptosi
human
osteosarcoma
cell
upregul
inactiv
jnk
pathway
addit
singl
bioactiv
compound
extract
ar
also
exhibit
inhibitori
activ
cancer
exampl
ar
water
extract
could
markedli
inhibit
prolifer
induc
apoptosi
breast
cancer
cell
includ
via
inhibit
signal
pathway
figur
find
provid
new
insight
anticanc
effect
ar
extract
promis
agent
breast
cancer
treatment
moreov
antitumor
effect
ar
water
extract
also
assess
subcutan
tumor
human
colorect
cancer
cell
line
graft
nude
mice
result
show
ar
water
extract
could
inhibit
growth
colorect
cancer
vivo
without
appar
toxic
side
effect
suggest
ar
potenti
therapeut
drug
colorect
cancer
respiratori
diseas
mainli
includ
asthma
bronchiti
chronic
obstruct
pulmonari
diseas
pulmonari
fibrosi
serious
reduc
qualiti
human
life
main
characterist
respiratori
diseas
includ
inflamm
excess
secret
respiratori
mucu
pulmonari
fibrosi
substanti
evid
exist
ar
main
compon
exhibit
inhibitori
activ
varieti
respiratori
diseas
effect
biolog
function
main
mechan
link
treatment
respiratori
diseas
ar
main
compon
summar
figur
asthma
chronic
airway
inflammatori
diseas
associ
wide
rang
symptom
includ
prolong
inflamm
airway
hyperrespons
mucu
hypersecret
airway
remodel
airway
inflamm
one
distinct
characterist
asthma
directli
link
helper
associ
disord
due
imbal
imbal
cytokin
caus
immun
dysfunct
stimul
goblet
cell
secret
excess
mucu
asthma
regulatori
cell
treg
play
vital
role
regul
immun
function
role
asthma
pathogenesi
increasingli
recogn
forkhead
famili
transcript
factor
predominantli
express
cell
regard
faith
marker
treg
also
critic
compon
treg
develop
function
found
ar
extract
could
significantli
increas
popul
treg
cell
promot
mrna
express
enhanc
respons
inhibit
respons
therebi
inhibit
inflamm
rat
model
asthma
suggest
antiasthmat
effect
ar
least
partial
associ
treg
figur
anoth
similar
studi
show
asiv
also
could
attenu
allerg
inflamm
regul
cytokin
enhanc
cell
ovalbumininduc
asthma
figur
besid
previou
studi
reveal
mtor
signal
pathway
downstream
signal
pathway
close
relat
prolifer
differenti
cell
play
import
role
patholog
process
asthma
inhibit
mtor
could
attenu
key
characterist
allerg
asthma
includ
airway
inflamm
airway
hyperreact
goblet
cell
metaplasia
observ
asiv
could
significantli
amelior
airway
inflamm
inhibit
signal
pathway
establish
murin
model
asthma
figur
er
stress
induc
cell
apoptosi
damag
dna
also
play
import
role
develop
asthma
perk
pkrlike
er
kinas
inositolrequir
transmembran
kinaseendonucleas
activ
transcript
factor
three
class
stress
sensor
express
er
membran
close
involv
product
er
stress
subtyp
relat
excess
secret
mucin
respiratori
tract
found
ap
inhibit
er
stress
inhibit
express
perk
figur
decreas
express
inhibit
express
respiratori
tract
figur
moreov
ap
inhibit
express
inflammatori
factor
inhibit
signal
pathway
figur
thu
conclud
ap
could
effect
inhibit
asthma
inhibit
er
stress
reduc
excess
secret
respiratori
mucu
respiratori
inflamm
ovalbumininduc
sever
asthma
mice
grow
evid
suggest
emt
play
critic
role
develop
pulmonari
fibrosi
cytokin
transform
growth
function
serv
import
mediat
fibrogenesi
plenti
work
identifi
import
profibrot
factor
shown
induc
emt
pulmonari
fibrosi
thu
antiemt
pathway
method
inhibit
signal
could
provid
novel
potenti
target
treatment
pulmonari
fibrosi
besid
forkhead
box
transcript
factor
involv
pulmonari
fibrosi
suppress
activ
result
hyperphosphoryl
akt
found
close
link
progress
pulmonari
fibrosi
demonstr
asiv
could
suppress
pathway
activ
thu
prevent
emt
bleomycininduc
pulmonari
fibrosi
figur
addit
inhibit
notch
signal
prove
potenti
therapeut
strategi
pulmonari
fibrosi
anoth
studi
design
investig
antifibrosi
effect
possibl
mechan
ar
inject
bleomycininduc
pulmonari
fibrosi
rat
reveal
ar
inject
could
exert
protect
effect
bleomycininduc
pulmonari
fibrosi
via
downregul
lung
figur
bronchopulmonari
dysplasia
bpd
defin
common
form
chronic
lung
damag
prematur
infant
includ
barotrauma
volutrauma
oxygen
toxic
known
epiderm
growth
factorlik
domain
secret
endotheli
cell
wide
distribut
lung
heart
spleen
play
import
role
angiogenesi
found
gene
express
significantli
decreas
neonat
rat
lung
follow
exposur
hyperox
condit
identifi
potenti
therapeut
target
lung
injuri
found
ap
could
exert
protect
effect
newborn
rat
bronchopulmonari
dysplasia
upregul
express
lung
tissu
figur
addit
find
provid
evid
asiv
could
exert
protect
effect
paraquatinduc
lung
injuri
mice
suppress
signal
pathway
anoth
studi
conduct
assess
effect
safeti
oral
ar
prevent
frequent
episod
acut
respiratori
tract
infect
arti
children
result
indic
intak
ar
alon
combin
drug
effect
enhanc
immun
function
prevent
upper
respiratori
tract
infect
children
increas
evid
indic
ar
main
compon
also
exhibit
inhibitori
activ
varieti
nervou
system
diseas
mainli
includ
cerebr
ischemia
injuri
chemotherapyinduc
neuropathi
neurodegen
diseas
sever
mechan
link
ar
main
compon
treatment
nervou
system
diseas
summar
figur
proven
mitochondri
dysfunct
emerg
key
event
link
alter
metabol
neuron
death
stabil
mitochondri
structur
function
essenti
neuron
surviv
ischem
injuri
bind
hexokinaseii
hkii
mitochondria
demonstr
protect
mitochondri
function
ischem
injuri
thu
pharmacolog
intervent
preserv
mitochondri
hkii
shown
protect
mitochondri
function
reduc
apoptosi
ischem
brain
found
asiv
could
protect
integr
mitochondri
function
inhibit
express
apoptosisrel
protein
protect
ischem
brain
tissu
damag
activ
akt
promot
hkii
bind
mitochondria
ischem
injuri
mice
figur
plenti
studi
identifi
function
microrna
mirna
ischem
diseas
among
identifi
mirna
specif
mirna
nervou
system
aberr
express
contribut
patholog
condit
relat
central
nervou
system
member
group
iii
lim
domain
protein
famili
neg
regul
activ
signal
pathway
regul
central
nervou
system
injuri
observ
asiv
could
decreas
express
upregul
express
therebi
activ
signal
pathway
exert
antiapoptot
anticerebr
ischem
effect
hypoxiainduc
injuri
cell
figur
anoth
studi
also
demonstr
protect
effect
ap
hypoxiainduc
neural
stem
cell
injuri
upregul
inhibit
jnk
pathway
figur
similar
asiv
exert
signific
protect
effect
decreas
apoptot
ratio
attenu
ro
overproduct
hydrogen
peroxideexpos
human
neuron
cell
cell
decreas
express
increas
express
tyrosin
hydroxylas
th
cell
via
signal
pathway
figur
besid
mapk
pathway
play
vital
role
transduc
extracellular
stimuli
seri
intracellular
phosphoryl
cascad
ultim
lead
cell
differenti
prolifer
surviv
death
erk
one
major
mapk
subfamili
activ
inflammatori
cytokin
extracellular
stressor
activ
rafmekerk
pathway
shown
key
regul
neuron
apoptosi
make
pathway
import
molecular
target
neurodegen
diseas
therapi
accordingli
highthroughput
compar
proteom
approach
base
investig
possibl
mechan
action
involv
neuroprotect
effect
asiv
glutamateinduc
neurotox
cell
data
indic
protein
associ
signal
transduct
immun
system
signal
molecul
interact
energi
metabol
play
import
role
neuroprotect
effect
asiv
rafmekerk
pathway
involv
neuroprotect
effect
asiv
glutamateinduc
neurotox
cell
figur
isoflavonoid
isol
ar
also
receiv
much
attent
due
variou
health
benefit
plenti
work
suggest
benefici
effect
isoflavonoid
mediat
antioxid
activ
neuroprotect
role
direct
antioxid
effect
isoflavonoid
investig
use
cell
model
result
show
three
isoflavonoid
formononetin
ononin
calycosin
could
prevent
decreas
activ
antioxid
enzym
superoxid
dismutas
sod
glutathion
peroxidas
gshpx
deplet
gsh
glutamatedamag
cell
indic
compound
could
protect
cell
oxid
stress
induc
glutam
isoflavon
could
also
protect
integr
membran
structur
inhibit
nerv
injuri
inhibit
releas
lactat
dehydrogenas
ldh
glutamateinduc
injuri
cell
figur
brief
overview
report
potenti
effect
calycosin
sever
diseas
possibl
mechan
show
calycosin
possess
function
antioxid
neuroprotect
role
inhibit
phosphoryl
downstream
mapk
signal
pathway
could
effect
inhibit
product
rosmda
promot
product
sodgshpx
addit
previou
studi
impli
ar
extract
potenti
nerv
growthpromot
factor
benefici
growth
peripher
nerv
axon
recent
studi
also
support
ar
extract
modul
local
inflammatori
condit
enhanc
nerv
regener
potenti
increas
recoveri
sever
peripher
nerv
injuri
rat
sciatic
nerv
transect
model
protect
properti
ar
extract
oxaliplatininduc
neurotox
also
investig
ar
extract
show
signific
antioxid
protect
effect
oxaliplatininduc
lipid
peroxid
dna
oxid
oxaliplatininduc
nerv
injuri
cell
parkinson
diseas
pd
incur
progress
diseas
character
shake
rigid
slow
movement
difficulti
walk
antioxid
antiinflammatori
drug
reliev
experiment
parkinson
symptom
well
known
famili
transcript
factor
effect
regul
inflammatori
respons
tlr
class
pattern
recognit
receptor
regul
involv
variou
inflammatori
respons
express
level
significantli
increas
blood
brain
pd
patient
besid
mapk
pathway
also
play
crucial
role
inflammatori
respons
found
calycosin
could
attenu
mptp
induc
pd
suppress
activ
mapk
pathway
indic
potenti
drug
calycosin
pd
figur
addit
ap
also
good
therapeut
effect
treatment
pd
confirm
ap
could
attenu
mptpinduc
motor
dysfunct
increas
proport
thposit
cell
revers
mptpinduc
mitochondri
structur
damag
reduc
mptpinduc
high
level
ro
increas
mptpinduc
decreas
mitochondri
membran
potenti
moreov
ap
also
decreas
ratio
cytochromec
protein
express
substantia
nigra
mous
pd
model
similar
ap
shown
protect
effect
oxid
metabolit
dopamin
induc
pd
like
due
allevi
oxid
stress
regul
apoptosi
pathway
cholinerg
system
figur
addit
cardiovascular
diseas
diabet
mellitu
cancer
respiratori
diseas
nervou
system
diseas
ar
bioactiv
compound
also
report
variou
therapeut
use
exampl
asiv
could
protect
progress
renal
fibrosi
inhibit
inflamm
via
signal
pathway
ap
possess
high
potenti
wound
heal
associ
inhibit
inflamm
acceler
cell
cycl
promot
secret
repair
factor
ar
extract
could
attenu
inflamm
oxid
stress
intestin
epitheli
cell
via
activ
respons
ar
extract
could
also
reduc
intestin
mucos
damag
promot
tissu
repair
inhibit
express
inflammatori
cytokin
lpsinduc
intestin
mucos
injuri
mice
proven
ar
extract
could
also
reduc
product
melanin
inhibit
melanogenesi
activ
erk
signal
pathway
melanoma
cell
conclus
indispens
herbal
drug
wide
use
clinic
practic
ar
play
crucial
role
healthcar
increas
number
extract
activ
compound
isol
immunomodul
antioxid
antiinflamm
antitumor
activ
among
other
found
effect
treatment
cardiovascular
diseas
diabet
mellitu
cancer
respiratori
diseas
nervou
system
diseas
ar
also
report
verifi
vivo
vitro
experi
increas
popular
studi
ar
develop
model
biolog
evalu
pharmacolog
activ
ar
bioactiv
compound
clarifi
futur
pharmacokinet
ar
water
extract
rat
report
previou
studi
eight
compound
includ
four
parent
formononetin
cg
ononin
asiv
four
metabolit
could
detect
singl
oral
administr
ar
water
extract
dose
gkg
gkg
male
rat
result
show
isoflavonoid
metabolit
major
type
constitu
absorb
plasma
plasma
concentr
four
metabolit
much
higher
parent
interestingli
daidzein
aglycon
compound
found
ar
water
extract
metabolit
could
detect
plasma
could
specul
daidzein
could
gener
formononetin
ononin
calycosin
glycosid
demethyl
dehydroxyl
deglycosyl
gastrointestin
tract
glucuronid
enterocyt
moreov
plasma
concentr
calycosin
major
constitu
ar
low
detect
one
reason
may
rate
glucuronid
calycosin
fast
enterocyt
calycosin
enter
system
circul
anoth
may
calycosin
enterocyt
could
excret
intestin
tract
transport
circul
enterocyt
gastrointestin
tract
earlier
similar
studi
report
absorpt
metabol
ar
water
extract
use
comput
chemistri
predict
method
cell
monolay
model
experi
improv
rat
evert
gut
sac
experi
healthi
human
volunt
experi
accord
silico
comput
result
compound
ar
could
regard
oral
avail
compound
includ
flavonoid
vitro
vivo
experi
compound
tent
identifi
involv
parent
compound
metabolit
flavonoid
ar
includ
isoflavon
pterocarpan
isoflavan
could
absorb
metabol
intestin
major
metabolit
glucuronid
addit
absorb
compon
pharmacokinet
profil
oral
administr
ar
water
extract
investig
cyclophosphamideinduc
immunosuppress
balbc
mice
result
compound
ar
extract
prototyp
compound
nine
metabolit
detect
mice
plasma
also
observ
flavonoid
saponin
two
main
kind
constitu
detect
plasma
mice
administr
ar
oral
among
absorb
constitu
flavonoid
triterpenoid
saponin
account
almost
threequart
compound
addit
pharmacokinet
studi
ar
ethanol
extract
also
report
six
main
bioactiv
compon
includ
cg
ononin
calycosin
formononetin
asiv
astragalosid
ii
rat
plasma
detect
oral
administr
ethanol
extract
ar
furthermor
pharmacokinet
behavior
bioactiv
compound
oral
administr
ar
extract
also
analyz
shown
tabl
eight
major
compound
includ
formononetin
cg
ononin
asiv
metabolit
achiev
maximum
plasma
concentr
within
h
demonstr
rapid
absorpt
gastrointestin
tract
rat
among
compound
cmax
metabolit
highest
follow
metabolit
parent
compound
cg
ononin
lowest
cmax
suggest
cg
ononin
could
rapidli
transform
glucuronid
hydrolyz
glucuronid
moreov
eight
detect
compound
rel
slow
elimin
anoth
studi
pharmacokinet
studi
five
bioactiv
compound
includ
cg
ononin
calycosin
formononetin
asiv
analyz
oral
administr
ar
water
extract
mice
four
isoflavonoid
formononetin
show
rel
slow
absorpt
elimin
tmax
h
h
tabl
meanwhil
doublepeak
phenomenon
common
phenomenon
absorpt
ar
flavonoid
found
specul
phenomenon
possibl
result
enterohepat
circul
transform
differ
compound
doublesit
absorpt
intestin
efflux
addit
asiv
show
rel
absorpt
slower
excret
reflect
data
cmax
h
tabl
pharmacokinet
studi
bioactiv
compound
oral
administr
ar
ethanol
extract
rat
also
report
observ
among
four
isoflavon
cg
ononin
calycosin
formononetin
detect
plasma
calycosin
absorb
elimin
rapidli
tmax
h
h
tabl
formononetin
absorb
elimin
slowli
among
four
isoflavon
tmax
h
h
tabl
valu
cmax
auc
calycosin
formononetin
plasma
higher
ononin
cg
although
content
calycosin
formononetin
ar
markedli
lower
ononin
cg
tabl
specul
phenomenon
might
part
ononin
cg
first
hydrolyz
enzymat
action
correspond
formononetin
calycosin
vivo
attribut
biotransform
flavonoid
glycosid
aglucon
intestin
bacteria
enzym
vivo
give
rise
great
increas
formononetin
calycosin
plasma
collect
studi
demonstr
isoflavonoid
saponin
metabolit
major
type
constitu
absorb
plasma
oral
administr
ar
extract
metabol
biotransform
extens
administr
ar
extract
vivo
figur
bioavail
barrier
bb
mainli
consist
drugmetabol
enzym
dme
efflux
transport
et
abundantli
distribut
liver
intestin
human
bodi
coupl
metabol
activ
dme
et
control
absorpt
distribut
metabol
excret
drug
taken
human
bodi
coupl
process
repres
signific
barrier
oral
bioavail
drug
dme
includ
phase
phase
ii
metabol
enzym
play
key
role
metabol
elimin
andor
detoxif
xenobiot
exogen
compound
introduc
bodi
cytochrom
cyp
abundantli
found
liver
gastrointestin
tract
lung
kidney
main
phase
enzym
phase
ii
enzym
mostli
transferas
includ
sulfotransferas
sult
glutathionestransferas
gst
uridin
udp
glucuronosyltransferas
ugt
nacetyltransferas
nat
variou
methyltransferas
human
et
mainli
includ
pglycoprotein
pgp
multidrug
resistanceassoci
protein
breast
cancer
resist
protein
bcrp
abundantli
express
mani
tissu
intestin
liver
kidney
brain
also
play
key
role
drug
absorpt
distribut
excret
increas
evid
indic
major
metabol
pathway
flavonoid
phase
ii
conjug
two
superfamili
phase
ii
enzym
ugt
sult
catalyz
format
hydrophil
phase
ii
conjug
flavonoid
plenti
work
also
identifi
et
involv
cellular
excret
flavonoid
phase
ii
conjug
one
hand
metabol
hydrophil
metabolit
hydrophil
conjug
transport
cell
transport
local
intestin
hand
flavonoid
conjug
transport
liver
may
subject
addit
metabol
excret
via
bile
taken
togeth
coupl
et
conjug
enzym
expect
signific
impact
bioavail
appar
halflif
flavonoid
formononetin
methoxyl
isoflavon
one
vital
bioactiv
compound
ar
possess
variou
pharmacolog
activ
pharmacokinet
paramet
formononetin
daidzin
determin
rat
follow
intraven
oral
administr
formononetin
tabl
observ
formononetin
extens
convert
metabolit
daidzin
daidzin
formononetin
conjug
glucuronid
andor
sulfat
plasma
concentr
conjug
formononetin
daidzin
gener
enzymat
hydrolysi
ugt
markedli
higher
parent
compound
formononetin
daidzin
anoth
studi
parallel
artifici
membran
permeabl
assay
permeabl
protein
bind
blood
uptak
characterist
pharmacokinet
metabol
formononetin
analyz
rat
permeabl
formononetin
found
high
formononetin
rapidli
absorb
system
circul
may
due
high
permeabl
lipophil
natur
oral
bioavail
formononetin
low
near
may
due
extens
firstpass
metabol
phase
oxid
metabol
phase
ii
glucuronid
andor
sulfat
intestin
liver
auc
formononetin
daidzin
conjug
glucuronid
andor
sulfat
higher
formononetin
daidzin
indic
formononetin
daidzin
conjug
main
exist
form
rat
plasma
oral
intraven
administr
reentri
peak
formononetin
daidzin
conjug
present
plasma
like
due
enterohepat
recircul
oral
well
intraven
administr
red
blood
cell
uptak
formononetin
independ
initi
rat
blood
concentr
time
plasma
protein
bind
formononetin
observ
high
addit
pharmacokinet
bioavail
vitro
absorpt
formononetin
oral
intraven
administr
rat
investig
found
formononetin
moder
bioavail
rat
absolut
bioavail
absorb
gastrointestin
segment
vari
permeabl
model
formononetin
show
moder
absorpt
via
passiv
diffus
studi
transport
metabol
formononetin
vivo
vitro
also
report
result
show
glucuronid
main
metabolit
intact
cell
model
coupl
conjug
enzym
et
determin
rate
direct
conjug
excret
excret
formononetin
glucuronid
mediat
multidrug
resistancerel
protein
mrp
organ
anion
transport
oat
locat
basolater
apic
membran
cell
cg
marker
use
routin
monitor
qualiti
ar
exhibit
sever
pharmacolog
activ
pharmacokinet
paramet
administr
cg
rat
display
tabl
one
studi
factor
influenc
cg
absorpt
disposit
determin
oral
administr
cg
cg
metabolit
rapidli
appear
plasma
sampl
cg
found
main
form
circul
plasma
suggest
deglycosyl
cg
calycosin
import
step
entri
system
circul
intraperiton
administr
cg
cg
rapidli
enter
system
circul
becam
main
circul
compon
plasma
therebi
limit
hydrolysi
liver
use
rat
intestin
perfus
model
cg
show
good
absorpt
cg
transport
lumen
enterocyt
mediat
sodiumdepend
glucos
transport
cg
like
hydrolyz
enterocyt
aglycon
calycosin
broadspecif
glucocerebrosidas
rapidli
metabol
calycosin
also
rapidli
extens
metabol
ugt
enterocyt
liver
moreov
metabolit
also
transport
lumen
bcrp
pharmacokinet
characterist
cg
determin
oral
administr
cg
rat
low
cumul
urinari
excret
cg
oral
administr
littl
cg
excret
urin
archetyp
suggest
cg
may
metabol
intestin
bacteria
low
concentr
detect
rat
plasma
indic
littl
cg
could
absorb
plasma
rat
gastrointestin
tract
hepat
firstpass
effect
well
ugtmedi
metabol
could
account
low
detect
cg
plasma
urin
ononin
glycosid
form
formononetin
also
one
major
isoflavonoid
ar
biolog
activ
pharmacokinet
paramet
administr
ononin
rat
display
tabl
pharmacokinet
bioavail
vitro
absorpt
ononin
investig
oral
intraven
administr
rat
oral
administr
ononin
show
doublepeak
phenomenon
plasma
concentr
profil
first
peak
observ
around
min
indic
rapid
absorpt
ononin
also
demonstr
ononin
could
biotransform
formononetin
via
colon
microbiotamedi
deglycosyl
moreov
ononin
may
deglycosyl
lactasephlorizin
hydrolas
enzym
found
brush
border
mammalian
small
intestin
small
intestin
ononin
rel
low
bioavail
sinc
ononin
rapidli
biotransform
gut
gener
formononetin
metabol
besid
oral
administr
ononin
small
absorpt
small
intestin
part
absorb
larg
intestin
segment
intestin
permeabl
ononin
poor
propos
altern
contributor
poor
bioavail
addit
bidirect
transport
assay
perform
investig
whether
efflux
transport
involv
absorpt
ononin
observ
ononin
substrat
pgp
low
bioavail
might
partial
attribut
efflux
absorpt
abund
saponin
characterist
compound
ar
asiv
document
chemic
marker
qualiti
control
ar
pharmacokinet
behavior
pure
asiv
ingest
rat
dog
wide
studi
clearli
elucid
tabl
earli
studi
pharmacokinet
tissu
distribut
asiv
rat
dog
examin
intraven
administr
rat
asiv
show
moder
fast
elimin
slowli
clear
via
hepat
clearanc
asiv
show
extens
distribut
multipl
tissu
follow
rapid
elimin
tissu
highest
concentr
asiv
detect
lung
liver
howev
limit
distribut
brain
indic
asiv
may
difficulti
penetr
bloodbrain
barrier
addit
parent
asiv
recov
urin
fece
suggest
near
asiv
may
undergo
metabol
vivo
intraven
administr
dog
asiv
also
show
moder
fast
elimin
slowli
clear
via
hepat
clearanc
anoth
studi
beagl
dog
found
absolut
bioavail
asiv
beagl
dog
fairli
low
would
restrict
applic
oral
administr
also
confirm
asiv
low
gastrointestin
tract
absorpt
bioavail
rat
anoth
studi
moreov
protein
bind
rate
asiv
mean
asiv
bound
extens
plasma
protein
form
associ
pattern
dog
plasma
author
claim
taken
account
asiv
consid
clinic
use
togeth
high
protein
bind
drug
addit
two
studi
report
absorpt
asiv
perfus
rat
intestin
model
transport
uptak
cell
monolay
vivo
bioavail
rat
oral
dose
found
transport
asiv
predominantli
via
passiv
rout
asiv
low
fraction
dose
absorb
human
mainli
due
poor
intestin
permeabl
high
molecular
weight
low
lipophil
well
paracellular
transport
may
directli
result
low
permeabl
passiv
transport
besid
asiv
prove
substrat
pgp
poor
absorpt
due
action
efflux
protein
recent
research
author
profil
metabolit
asiv
rat
plasma
bile
urin
fece
sampl
oral
administr
total
metabolit
includ
phase
ii
metabolit
detect
tent
identifi
major
metabol
pathway
asiv
rat
hydrolysi
glucuronid
sulfat
dehydrogen
addit
asiv
metabol
aglycon
deglycosyl
gastrointestin
tract
absorb
partial
anoth
recent
studi
author
investig
enterohepat
circul
asiv
evalu
impact
activ
intestin
microbiota
deposit
asiv
rat
oral
intraven
administr
asiv
metabol
intestin
bacteria
form
brachyosid
b
bra
b
cyclogaleginosid
b
cyc
b
cycloastragenol
ca
isocycloastragenol
isoca
dehydrogen
metabolit
ca
asiv
two
metabolit
ca
isoca
circul
blood
plasma
distribut
asiv
significantli
affect
bile
duct
drainag
asiv
administr
duodenum
rat
pretreat
antibiot
metabol
asiv
intestin
microbiota
markedli
inhibit
moreov
variat
intestin
microbiota
may
chang
disposit
asiv
similar
studi
also
confirm
bacteria
play
crucial
role
metabol
biotransform
asiv
vivo
conclud
ar
possess
variou
biolog
function
play
indispens
role
healthcar
throughout
chines
histori
thousand
year
howev
far
relationship
dose
efficaci
ar
still
clearli
clarifi
reflect
cur
effect
ar
vari
greatli
differ
individu
accord
histor
literatur
modern
clinic
report
dose
ar
administr
rang
g
g
far
exce
dose
g
record
latest
chines
pharmacopoeia
among
patient
syndrom
blood
stasi
patient
display
markedli
attenu
diseas
oral
ar
administr
dose
less
g
patient
insensit
cur
effect
ar
among
anoth
patient
similar
syndrom
oral
administr
ar
dose
g
patient
cure
correspond
cure
rate
addit
among
patient
malign
tumor
ar
administr
differ
dose
could
irregularli
allevi
advers
reaction
caus
chemotherapi
drug
clinic
statist
clearli
show
signific
differ
reaction
ar
efficaci
among
differ
patient
similar
syndrom
therefor
person
use
ar
repres
novel
strategi
necessari
obtain
ar
enhanc
efficaci
precis
treatment
bb
mainli
consist
dme
et
abundantli
distribut
liver
intestin
human
bodi
one
hand
bb
act
critic
xenobiot
detoxif
system
play
crucial
role
protect
human
bodi
possibl
toxic
extern
chemic
hand
bb
control
absorpt
distribut
metabol
excret
drug
taken
human
bodi
bb
regul
pharmacokinet
behavior
drug
vivo
therebi
determin
concentr
drug
thu
close
link
bb
network
drug
efficaci
divers
polymorph
dme
et
individu
markedli
influenc
pattern
pathway
coupl
bb
network
notabl
produc
differ
pharmacokinet
behavior
drug
ultim
result
variat
efficaci
drug
differ
individu
therefor
bb
network
could
use
key
determin
clinic
implement
person
medicin
result
pharmacokinet
studi
ar
conclud
wellrecogn
coupl
ugt
et
play
crucial
role
regul
bioavail
bioactiv
compound
ar
thu
specul
divers
polymorph
ugt
et
patient
similar
syndrom
could
notabl
produc
differ
reaction
ar
efficaci
would
lead
blind
treatment
could
easili
result
ineffect
treatment
transcriptom
studi
show
genet
polymorph
ugt
extens
exist
differ
individu
directli
regul
efficaci
toxic
drug
differ
individu
exampl
patient
carri
allel
increas
risk
medium
high
dose
irinotecaninduc
sever
diarrhea
patient
wildtyp
ugt
famili
gene
lower
rate
toxic
associ
irinotecan
treatment
certain
mutat
allel
addit
genet
polymorph
may
play
modest
role
lamotrigin
clearanc
chang
pregnanc
furthermor
confirm
larg
number
polymorph
gene
shown
modul
ugt
gene
promot
activ
enzymat
activ
thu
ugt
polymorph
reduc
capac
glucuronid
carcinogen
type
cancerpromot
molecul
eg
sex
hormon
associ
increas
risk
develop
cancer
moreov
polymorph
independ
risk
factor
poor
absorb
posaconazol
oral
suspens
patient
hematolog
malign
genet
polymorph
et
markedli
alter
pharmacokinet
behavior
drug
also
close
relat
toxic
efficaci
clinic
drug
exampl
pgp
polymorph
may
impact
effect
antipsychot
concentr
target
cell
via
mediat
agent
transport
distribut
signific
associ
sorafenib
exposur
studi
polymorph
observ
snp
patient
treatment
sorafenib
hepatocellular
carcinoma
rheumatoid
arthritispati
carri
wildtyp
allel
might
benefit
pgp
inhibit
administr
glucocorticoid
analog
nonpgp
substrat
besid
bodi
disposit
lumefantrin
also
notabl
influenc
genotyp
among
patient
uncompl
plasmodium
falciparum
malaria
polymorph
increas
atpas
activ
lead
greater
efflux
sorafenib
genet
polymorph
also
strongli
influenc
interindividu
variat
telmisartan
pharmacokinet
renal
transplant
recipi
grow
evid
suggest
genet
polymorph
also
close
relat
interindividu
variat
therapeut
perform
bcrp
g
c
polymorph
significantli
associ
lowest
sorafenib
plasma
level
patient
treatment
sorafenib
hepatocellular
carcinoma
common
singl
nucleotid
polymorph
reduc
cell
surfac
express
protein
result
lower
efflux
substrat
consequ
higher
plasma
concentr
substrat
observ
patient
carri
allel
collect
clinic
use
ar
person
medicin
necessari
achiev
better
accur
therapeut
efficaci
polymorph
ugt
et
import
determin
interindividu
differ
toxic
respons
mani
drug
also
play
crucial
role
regul
pharmacokinet
behavior
ar
vivo
thu
genet
polymorph
ugt
et
differ
individu
appli
character
optim
person
therapi
ar
clinic
futur
effect
safe
herbal
drug
wide
use
treat
variou
diseas
ar
play
indispens
role
healthcar
china
countri
worth
mention
ar
popular
herb
frequent
coadminist
mani
herbal
chemic
drug
efficaci
improv
clinic
accord
histor
literatur
modern
clinic
report
ar
use
essenti
ingredi
chines
herb
prescript
treat
variou
complic
diseas
howev
potenti
risk
herbherb
herbdrug
interact
intens
exist
combin
therapi
clinic
could
easili
caus
undesir
variat
plasma
concentr
coadminist
drug
therebi
result
treatment
failur
toxicolog
unsaf
consequ
therefor
potenti
herbherb
herbdrug
interact
aris
coadministr
ar
herbal
chemic
drug
must
evalu
studi
need
conduct
confirm
safe
combin
therapi
ar
modern
pharmacolog
studi
clinic
practic
provid
evid
effect
function
ar
accord
result
variou
valid
vivo
vitro
studi
ar
prove
possess
multipl
biolog
function
immunomodul
antioxid
antiinflamm
antitumor
properti
thu
wide
ingest
treatment
cardiovascular
diseas
diabet
mellitu
cancer
respiratori
diseas
nervou
system
diseas
diseas
last
decad
underli
molecular
mechan
involv
therapeut
effect
ar
wide
studi
report
investig
need
variou
complic
compound
contain
ar
lead
divers
complex
molecular
target
interven
ar
phytochem
studi
indic
ar
mainli
contain
isoflavonoid
triterpen
saponin
polysaccharid
trace
element
date
compound
isol
identifi
ar
variou
biolog
activ
compound
confirm
among
isoflavonoid
saponin
polysaccharid
three
main
type
benefici
compound
respons
pharmacolog
activ
therapeut
efficaci
ar
studi
need
conduct
isol
identifi
new
compound
ar
get
comprehens
understand
ar
pharmacokinet
characterist
ar
bioactiv
compound
also
wide
perform
clearli
elucid
wellrecogn
metabol
biotransform
bioactiv
compound
extens
ingest
ar
isoflavonoid
saponin
metabolit
major
type
constitu
absorb
plasma
coupl
ugt
et
vivo
play
crucial
role
regul
pharmacokinet
characterist
determin
bioavail
bioactiv
compound
ar
thu
vari
polymorph
ugt
et
differ
individu
like
critic
factor
contribut
vast
dosag
differ
ar
ingest
individu
futur
clinic
practic
genet
polymorph
ugt
et
differ
individu
appli
character
optim
person
therapi
ar
achiev
better
accur
therapeut
efficaci
